Potential for sodium-glucose cotransporter-2 inhibitors in the management of metabolic syndrome: A systematic review and meta-analysis

Table 1 Jadad score of included studies

Ref.	Randomization	Blinding	Accountability	Jadad score
Bailey et al[24], 2015	2	1	1	4
Bailey et al[25], 2013	1	1	1	3
Rosenstock et al[26], 2012	1	1	1	3
Wilding et al[27], 2014	2	2	1	5
Matthaei et al[34], 2015	2	1	1	4
Jabbour et al[30], 2014	1	1	1	3
Anker et al[15], 2021	2	2	1	5
Sone et al[36], 2020	2	1	1	4
Bolinder et al[33], 2014	2	2	1	5
Rosenstock et al[37], 2015	2	1	1	4
Rosenstock et al[38], 2014	2	1	1	4
Kohan et al[28], 2016	1	1	1	3
Zinman et al[5], 2015	2	1	1	3
Brown et al[35], 2020	1	1	1	3
Qin et al[32], 2019	1	U	U	1
Gause-Nilsson 20141	1	U	U	1
List et al[39], 2009	1	1	1	3
McMurray et al[31], 2019	2	2	1	5

¹No baseline data reported for Gause-Nilsson 2014.

U: Unclear.